Avantik Appoints Jeffrey Waldman as New CEO to Lead Growth Initiatives

Avantik's Leadership Transition: A New Era with Jeffrey Waldman

Avantik, a prominent player in the diagnostic lab solutions sector, has recently announced the appointment of Jeffrey Waldman as its new Chief Executive Officer. This decision marks a significant milestone for the company as it embarks on its next chapter of growth and expansion.

Jeffrey Waldman steps into the role following the retirement of Mark Zacur, who played a crucial part in Avantik's evolution into a nationwide provider of essential equipment, consumables, and service solutions for diagnostic laboratories. Under Zacur's leadership, Avantik successfully doubled its national service footprint and broadened its offerings through strategic acquisitions.

Waldman's extensive background in healthcare leadership spans over two decades, highlighting his capability to drive organizational success. Before joining Avantik, he served in various leadership roles, notably at Henry Schein, where he executed critical strategies and operations that propelled company growth. His tenure included significant contributions to the global orthopedic sector, enhancing product lines and customer relations.

Furthermore, Waldman was at the forefront of transforming National HME into a key player in hospice equipment services, showcasing his knack for fostering high-performing business environments. His robust track record makes him a fitting choice to lead Avantik as it aims to reinforce its customer relationships and enhance service delivery.

Scott Garrett, Chairman of Avantik, expressed confidence in Waldman's ability to build upon the firm’s established foundation. He emphasized that Waldman’s focus on customer-centric strategies resonates perfectly with Avantik’s mission. He noted, “Jeff stood out to us as the ideal leader to build on Avantik's strong foundation and advance our momentum.”

Zacur, the outgoing CEO, reflected on his time at Avantik, expressing gratitude for the collaborative effort of the team and the significant growth they achieved together. He stated that transitioning leadership at this point is essential for the company to continue thriving as it faces evolving market demands. Notably, he will remain as an advisor until the end of the year to ensure a smooth transition for Waldman and the executive team.

In his acceptance of the CEO position, Waldman expressed his eagerness to contribute to Avantik's mission. He stated, “I’m honored to join Avantik, which has built a differentiated, one-solution approach that customers rely on every day.” His commitment to strengthening customer relationships and ensuring that Avantik's solutions continue to support diagnostic labs in delivering patient care is evident.

Founded in 1971, Avantik has positioned itself as a trusted partner for anatomic pathology, histology, and dermatology laboratories. The company's extensive inventory, coupled with a national network of field service engineers, underscores its commitment to maintaining critical lab operations. The rapid response time and broadest product portfolio have been pivotal in achieving high levels of customer satisfaction, a core value for the organization.

Avantik’s partnership with Water Street Healthcare Partners in 2023 exemplifies its intention to expand and innovate within the diagnostic laboratory solutions market. As Waldman steps into the CEO role, all eyes will be on how he steers the company through the competitive landscape, fostering growth while ensuring the satisfaction and trust of its valued customers.

As Avantik readies itself for this new chapter, the appointment of Jeffrey Waldman signals a renewed commitment to excellence and leadership within the healthcare solutions domain. The future certainly seems promising for Avantik under Waldman's guidance, as it continues to prioritize quality, customer service, and innovative solutions to meet the ever-evolving needs of healthcare providers.